Read By Title:

Session Schedule

#368 THE PREVALENCE OF MAJOR ABNORMALITIES OF THE LEVATOR ANI IN UROGYNAECOLOGICAL PATIENTS

#369 Comparison of urethral pressure profiles between nulli parous and ex-breeder anaesthetised beagles.

#370 The Distribution of Pelvic Organ Support in Korea Population Women

#371 Refining ACT balloon placement: anatomical relationship between adjustable continence therapy (ACT) balloon (and Trocar) and female erectile tissue.

#372 NEONATAL EXPOSURE TO ENVIRONMENTAL DISRUPTORS DECREASES ESTROGEN RECEPTOR-beta AND SUPPRESSES APOPTOSIS OF THE PROSTATE AFTER PUBERTY

#373 TGF beta1 regulates cell differentiation and causes the up-regulation of connective tissue growth factor in human prostate stromal cell

#374 Xestospongin diminishes overactive contractions in the obstructed guinea pig bladder.

#375 Highly expression of Angiotensin Ⅱ type-1 receptor (AT1) in the rat detrusor muscle with bladder outlet obstruction

#376 The novel use of telemetry to monitor bladder function in the conscious rat.

#377 Does Over-working Impair Quality of Life?

#378 Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist compared with oxybutynin in the treatment of patients with overactive bladder

#381 Factors Correlated With Urge Urinary Incontinence Following Surgery for Stress Incontinence

#382 Improvement in Urgency Perception After Tolterodine Treatment Is Associated With Patient Satisfaction With Treatment

#384 Interstitial cells in the bladder wall identified by an antibody to the c-Kit receptor ACK-2

#385 Novel unstable bladder model in hypercholesterolemia rat

#386 Assessment of Transdermal Oxybutynin in Overactive Bladder: Naive and Previously Treated Patients

#387 LOCAL NITRIC OXIDE PRODUCTION IS INVOLVED IN SUPPRESSION OF CAPSAICIN-INDUCED DETRUSOR OVERACTIVITY IN THE RAT

#388 INVOLUNTARY CONTRACTION AWARENESS AND BLADDER STRENGTH IN MEN WITH IDIOPATHIC DETRUSOR OVERACTIVITY

#389 Responder rates, a better way to express drug efficacy: data from darifenacin pooled phase III studies

#390 WHAT HAPPENS TO WOMEN ON TREATMENT FOR OVERACTIVE BLADDER

#394 LOW-DOSE BOTULINUM-A TOXIN INJECTIONS INTO DETRUSOR MUSCLE: EFFECT ON CONSERVATION OF MICTURITIONS

#395 Efficacy, Safety, and Tolerability of Tolterodine for Overactive Bladder: Comparable Profiles Between Male and Female Patients

#396 GABAPENTIN FOR OVERACTIVE BLADDER AND NOCTURIA AFTER ANTICHOLINERGIC FAILURE

#399 Resource utilisation and utility following treatment of stress urinary incontinence with the Zuidex system

#400 Prevalence and associations of nocturnal enuresis and nocturia in the community

#402 Bladder tuberculosis

#403 Diet and Lifestyle factors associated with Over-active Bladder in Men: A prospective study

#404 A web-based comparison of two questionnaires for assessing the severity of urinary incontinence: the ICIQ-UI SF versus the Incontinence Severity Index

#405 Prevalence of Nocturia and Risk Factors for Frequent Nighttime Micturition in a Community-dwelling Japanese Elderly Population

#406 Help-seeking and treatment provision in men and women with incontinence.

#408 Social factors and storage disorder: a cross-sectional study

#409 Extended Release Formulations of Oxybutynin and Tolterodine for the Treatment of Overactive Bladder: A German Health Economic Analysis

#410 A cost-consequences analysis of physiotherapy and surgery for stress urinary incontinence

#411 Female urinary incontinence : a cross-sectional study from a rural area

#412 Pelvic Organ Prolapse in Women: Is there a relationship with Constipation and Dietary Fiber Intake?

#413 Prevalence of Urinary Incontinence in a Gynecologic Oncology Population

#414 A Survey of General Practitioners on Female Urinary Incontinence and Pelvic Organ Prolapse

#415 The Impact of Overactive Bladder on Family Members

#416 ASSOCIATION OF THE BRINK DIGITAL PELVIC MUSCLE SCORE WITH DEMOGRAPHIC AND CLINICAL CHARACTERISTICS IN WOMEN SCHEDULED TO UNDERGO ANTI-INCONTINENCE SURGERY

#417 WHAT IS THE PAIN OF INTERSTITIAL CYSTITIS LIKE?

#418 Faecal Continence and Pudendal Nerve Function in Older Women - Does Vaginal Delivery or Age have the Greatest Impact?

#419 RELATIONSHIP BETWEEN URINARY VOLUME AND LOWER URINARY TRACT SYMPTOMS ASSESSED BY FREQUENCY VOLUME CHART IN WOMEN IN COMMUNITY-BASED STUDY

#420 A Model For Explaining Differences In Incontinence Care Seeking (MEDICS Project)

#421 The National Continence Hotline- A One Year Snapshot, July 2002 - June 2003

#423 Cesarean section as one of common causes of urinary tract fistulas

#424 Age induced changes in muscarinic receptor subtypes mediating urinary bladder contraction.

#425 Health factors associated with voiding symptoms in older men and women

#426 Urinary retention in elderly women due to lumbar spondylosis; a reappraisal

#427 INCOndition: development and evaluation of a training programme to prevent or reduce urinary incontinence in older women in homes for the elderly

#428 INCONTINENCE AND ITS EFFECTS ON QUALITY OF LIFE OF OLDER PEOPLE LIVING IN RESIDENTIAL AND NURSING HOMES

#429 COMPARING THE ACCURACY OF CONVENTIONAL US AND DOPPLER PLANIMETRY IN THE DETERMINATION OF BLADDER VOLUME IN POSTPARTUM WOMEN

#430 Burden of testing in the assessment of fecal incontinence

#431 RADIOGRAPHIC EVALUATION OF VAGINAL AXIS AND POSITION OF THE APEX FOLLOWING 3 TECHNIQUES FOR VAGINAL VAULT SUSPENSION

#433 comparison of trans-obturator tape (TOT) and TVT using perineal ultrasound

#434 What is the real accuracy of ultrasound measurements?

#435 AN INDEPENDANT AUDIT OF MESH REPAIR FOR RECTOCELE PROLAPSE

#436 Transvaginal sonographic measurement of urethral length and vaginal wall thickness at anterior, mid, posterior urethra in incontinent and continent women

#437 3D ultrasound as a diagnostic method for incontinence

#438 THE CHANGES IN ULTRASOUND PICTURE AFTER TVT PROCEDURE

#440 DOES ULTRASOUND INVESTIGATION DIAGNOSE OVERACTIVE BLADDER?

#441 Influence of extensive periurethral preparation on urethral perfusion using Colour Doppler flow quantification

#442 Dynamic magnetic resonance

#443 Ultrasound evaluation of urinary incontinence

#445 THE MALE PERINEAL SLING FOR POST PROSTATECTOMY INCONTINENCE: PREDICTORS OF SUCCESS

#448 Experience of 4 years with Pro-ACT™ after initial learning curve

#451 IMPORTANCE OF THE PRESERVATION OF THE PUBOPROSTATIC LIGAMENT FOR THE URINARY CONTINENCE AFTER RADICAL PROSTATECTOMY.

#452 ADJUSTABLE CONTINENCE THERAPY (proACT), A NEW THERAPY OF THE MALE STRESS URINARY INCONTINENCE: 1 YEAR FOLLOW UP.

#453 IS THERE A RATIONAL BASIS FOR TREATING INCONTINENCE WITH THE MALE SLING? A CLINICAL AND URODYNAMIC STUDY.

#455 DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE ICIQ BOWEL SYMPTOMS MODULE: THE ICIQ-BS

#456 What are the prevalences of defecation symptoms during pregnancy and after childbirth?

#457 Anal Incontinence in Women Presenting for Gynecologic Care: Prevalence, Risk Factors and Impact Upon Quality of Life

#458 Risk factors for anal sphincter injuries associated with instrumental deliveries.

#459 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS INHIBITS FREQUENCY AND VOLUME OF MICTURITION TEMPORARY IN MALE RAT: DIFFERENCE BETWEEN CONSCIOUS AND ANESTHETIZED RATS

#460 Nocturnal polyuria index of the renal transplant recipients depends on the age of transplanted kidney graft

#461 Blood Flow and Ischemic Changes of the Rat Bladder to Short Term Partial Outlet Obstruction

#463 The association of ultrasound-estimated bladder-wall thickness with clinical parameters in male patients over 50 years old with lower urinary tract symptoms

#464 24- MONTH FOLLOW UP AFTER ROTORESECTION: A PROSPECTIVE STUDY

#465 The relation between I-PSS and the objective parameters in the diagnosis of boo: statistical analysis and application of ANN.

#466 THE EXPRESSION LEVEL OF ALPHA1-ADRENORECEPTOR SUBTYPE IN PROSRTATIC HYPERTROPHY

#467 THE LONG-TERM EFFICACY OF ALPHA1-BLOCKER (Tamsulosin) IN MEN WITH BENIGN PROSTASTIC HYPERPLASIA

#468 Improvement of lower urinary tract symptoms by sildenafil in benign prostate hypertrophy patients combined with erectile dysfunction

#469 Detrusor overactivity in patients With Benign Prostatic Obstruction: The clinical and urodynamic characteristics

#470 Efficacy of Low-dose Tamsulosin on Lower Urinary Tract Symptoms Suggestive of benign prostatic hyperplasia - a nonblind multicenter Korean nationwide scale study

#471 Combination treatment with an alpha1-blocker plus an anticholinergic for the patients with suspected bladder outlet obstruction (BOO) concomitant with over active bladder (OAB).

#473 PATHOPHYSIOLOGY AND SUBJECTIVE SYMPTOMS IN WOMEN WITH VOIDING DIFFICULTY

#474 How do the prevalences of urogenital symptoms change after the first childbirth?

#476 Physical and sexual violence and bladder symptoms – is there an association?

#478 Symptoms and clinical condition of Italian women presenting with LUTS in Urology Centres. The FLOW study

#479 THE IMPACT OF BODY MASS INDEX ON THE OCCURRENCE OF URINARY INCONTINENCE IN AN ADULT FEMALE POPULATION.

#481 Symptoms associated with sexual intercourse in female patients: The FLOW study

#482 RELATIONSHIP BETWEEN OVERACTIVE BLADDER (OAB) AND SEXUAL ACTIVITY IN WOMEN

#483 Psychosocial stress and overactive bladder in female

#484 Urinary retention in women: A retrospective study of its causes and treatment

#485 Treatments for stress urinary incontinence symptoms by patients referred to secondary care within a UK setting.

#487 Management of Italian women presenting with LUTS in Urology Centres: The FLOW study.

#488 Chronic pelvic pain in female patients with LUTS arriving at Urology Centres in Italy. The FLOW study.

#490 A Survey of Female Urinary Symptoms in a General Practice in the United Kingdom.

#491 Gabapentina treatment in female patients with OAB symptoms

#492 Influence of a preceding somatosensory pudendal stimulation on magnetic evoked external urethral sphincter (EUS) contraction is depending on its time interval

#493 Effects of acetylcholinesterase inhibitor on overactive bladder caised by cerebral infarction in rats

#494 Structural organisation of the interstitial cells of the bladder in different species: comparative data from human, rat and guinea pig bladders

#495 The Role of Epithelial Sodium Channels Expressed in the Rat Urinary Bladder Epithelium in Micturitional Reflex.

#496 GATING OF THE MICTURITION REFLEX BY ACTIVATION OF BLADDER C-AFFERENTS - AN EXPERIMENTAL STUDY IN THE CAT

#497 Estrogen receptors in central nervous system micturition pathways in a rat model

#498 The effects of imatinib mesylate (Glivec) as a c-Kit tyrosine kinase inhibitor in the guinea-pig urinary bladder ~ a possible new drug therapy for overactive bladder ~

#499 Falacies Of Leak Point Pressure in Patients With Neurogenic Bladder

#500 Acute tibial nerve stimulation to suppress bladder contractions in the cat

#501 DIFFERENT PARAMETERS FOR CHRONIC PUDENDAL NERVE STIMULATION WITH PUDENDAL PERCUTANEOUS IMPLANT (PPI) RELATED ON NEUROGENIC SITUATION.

#502 Sacral nerve stimulation is a durable treatment for idiopathic non-obstructive urinary retention

#503 The quantitative bladder sensory test: Evaluation of the neuroselective current perception threshold of the bladder sensory to identify patients with overactive bladder associated with sensory dysfunction

#506 Automated conditional neuromodulation of neurogenic detrusor overactivity using a combined sacral anterior and posterior nerve root stimulator in spinal cord injury.

#507 EFFECT OF THE SCHISTOSOMAL MIELOPATY TREATMENT WITH PRAZIQUANTEL ON THE NEUROGENIC BLADDER-SPHINCTER DYSFUNCTION: A PROSPECTIVE STUDY OF 65 PATIENTS

#508 A valsalvometer can be effective in standardising the valsalva manoeuvre

#509 Schistosomiasis of the spinal cord. Clinical and urodynamic presentation.

#510 ACUPUNCTURE FOR TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER REFRACTORY TO CONVENTIONAL PHARMACOTHERAPY

#511 An experimental approach on the pathophysiology of detrusor sphincter dyssynergia.

#512 ELECTROPHYSIOLOGIC FINDINGS IN THE PELVIC FLOOR OF PATIENTS WITH PROSTATE CANCER.

#513 Peripheral Nerve Evaluation versus First Stage Tined Lead in a MS patient population

#514 Lower urinary tract dysfunction of the patients with Parkinson disease: changes related to disease severity

#515 BOTULINUM A TOXIN (BOTOX) INJECTION FOR THE TREATMENT OF REFRACTORY OVERACTIVE BLADDER

#516 Sphincter Electomyography in patients with suspected Multiple System Atrophy

#517 Sacral nerve stimulation for overactive bladder symptoms in patients with brain damage: a pilot study

#519 Intensive Percutaneous Tibial Nerve Stimulation in the treatment of urge urinary incontinence does not increase the success rate

#521 NEUROPHYSIOLOGICAL ASSESSMENT DURING SACRAL AND PUDENDAL NERVE LEAD IMPLANT FOR NEUROMODULATION.

#522 CONDITION SPECIFIC QUALITY INDICATORS FOR INTERSTIM NEUROMODULATION THERAPY

#523 SELF-STERILIZING CATHETERS WITH TiO2 PHOTPCATALYST THIN FILMS FOR CLEAN INTERMITTENT CATHETERLIZATION: CLINICAL USE

#524 Voiding status after renal transplantation with the long-term arrested bladder

#525 Miniaturo-I: a novel device for the treatment of the Overactive Bladder Syndrome

#526 WHEN TO DO THE FIRST URODYNAMIC TESTS AFTER SPINAL CORD TRAUMA

#527 The value of basic non-invasive urodynamic investigation for screening and diagnosis of urinary disorders in patients with multiple sclerosis

#528 Incontinence storage phase symptom score (ISSS) – a new symptom questionnaire for urinary incontinence and overactive bladder syndrome

#529 Sexual Response in Patients With Sacral Neuromodulation for Lower Urinary Tract Symptoms or Fecal Incontinence.

#530 Improvement of Interstitial Cystitis symptoms after chronic pelvic floor electrostimulation: updated results of a multi-centre study.

#531 Bladder Perfusion In Interstitial Cystitis: A Study Of Bladder Blood Flow Using Laser Doppler Flowmetry

#532 Intravesical electromotive drug administration (experimental study)

#533 IMMUNOHISTOCHEMICAL ANALYSIS OF UROTHELIAL TRPV1 IN PATIENTS SUFFERING FROM INTERSTITIAL CYSTITIS WHO UNDERWENT INTRAVESICAL TREATMENT WITH RESINIFERATOXIN

#534 Common things are common. Complete re-evaluation of patients with a diagnosis of interstitial cystitis - a 7 year prospective study.

#535 A COMPUTERIZED “TELE-ASSISTED” FOLLOW-UP FOR PRIMARY NOCTURNAL ENURESIS: A 6-MONTHS PILOT STUDY

#536 Long term urological outcome of paediatric spinal cord injury.

#537 Video-urodynamic patterns in neurologically normal infants with and without vesicoureteral reflux

#538 PREDICTING 'DANGEROUS' BLADDERS IN CHILDREN: PROBLEMS IN USING AREA UNDER THE CURVE (AUC)

#539 Neurogenic bladder in children following spinal cord ischemia

#541 PRELIMINARY TESTING OF A SCREENER FOR LUTS IN PAEDIATRIC PATIENTS: THE ICIQ-S

#542 Effect of test position, using two different methods of measurement, on reliability of pelvic floor muscle strength assessment.

#544 Assessment of pelvic floor muscle exercises in women with incontinence and normal controls

#545 Anatomical and functional outcome after laparoscopic sacral colpo(perineo)pexy: a prospective follow up of 132 patients.

#546 Combined urinary and anal incontinence - a multidisciplinary approach

#547 Distribution of innervation zones of the external anal sphincter: effects of gender in healthy subjects

#548 Levator ani abnormalities seen with MR imaging after forceps delivery: does the length of the second stage matter?

#549 Acute Effects of Vaginal Distension in the Female Rat: Biomechanics and Histology

#550 Effect of pelvic floor contraction on desire to void

#551 Co-activation of the pelvic floor muscles during contraction of the hip external rotators

#552 Postpartum Urinary Incontinence: Regional Prevalence and the Impact of teaching pelvic muscle exercises to pregnant women with UI

#553 Obstetric anal sphincter injury:long-term outcome assessment after primary repair

#554 Assessing pelvic floor function in the elderly using transabdominal diagnosic ultrasound

#556 COMBINED PELVIC FLOOR CLINIC: A FOUR- YEAR REVIEW

#557 Pilotstudy: Outpatient pelvic floor exercises versus home biofeed back (PELVEX)

#558 Co relation between anal squeeze pressure and pelvic muscle squeeze- a prospective study of 117 patients

#559 MONARC TRANSOBTURATOR SUBURETHRAL SLING: EIGHTEEN MONTHS’ EXPERIENCE

#560 THE ASSESSMENT OF PELVIC FLOOR MUSCLE FUNCTION USING A NOVEL AND DIRECTIONALLY SENSITIVE INTRA-VAGINAL SENSOR PROBE

#563 PELVIC PAIN SYNDROME AND PSEUDODYSSINEGIA. IS IT THE CORRELATION?

#564 Biofeedback versus electrostimulation in treatment of female stress urinary incontinence

#565 Rho/ Rho kinase is predominantly present in the urothelium controlling the contraction of the human urinary bladder in vitro

#566 Muscarinic receptor binding characteristics of anticholinergic agents to treat overactive bladder, in human bladder and parotid gland

#567 Involvement of protease-activating receptor-2 in facilitation of neuromuscular purinergic transmission in the guinea-pig urinary bladder

#568 Immunohistochemical evidence for endocannabinoid production in the human detrusor

#569 THE EFFECTS OF ENDOTHELIN-1 AND YM598, A NOVEL SELECTIVE ENDOTHELIN ETA RECEPTOR ANTAGONIST, ON THE LOWER URINARY TRACT IN VITRO AND IN VIVO

#570 Carbachol induced calcium sensitization in rat urinary bladder

#571 Contractile role of M2 muscarinic receptors in urinary bladder smooth muscle

#572 EFFECTS INCREASING CONCENTRATIONS OF RESINIFERATOXIN ON THE MUCOSA OF THE FEMALE RAT BLADDER. PRELIMINARY RESULTS OF A HISTOPATHOLOGICAL AND IMUNOHISTOCHEMICAL PLACEBO-CONTROLLED STUDY

#573 ATP-engendered ATP release in the rat urinary bladder

#574 Effects of menthol on isolated detrusor smooth muscle and on the micturition reflex in rats

#577 COMPARATIVE BLADDER WALL TISSUE LEVELS OF RESINIFERATOXIN

#578 EFFECTS OF INTRAVENOUS TNP-ATP IN CONCIOUS RATS WITH BLADDER OUTFLOW OBSTRUCTION.

#579 Effectiveness of an anti-inflammatory drug, loxoprofen, in patients with nocturia

#580 Concomitant food intake does not significantly influence the pharmacokinetics of the novel, bladder-selective antimuscarinic fesoterodine

#581 Investigation on an individually adjusted oral trospium chloride (TC) therapy in patients suffering from neurogenic overactive bladder

#582 DAILY INTRAVESICAL INSTILLATION OF 1 µM OF NOCICEPTIN/ORPHANIN FQ FOR THE TREATMENT OF NEUROGENIC URINARY INCONTINENCE IN PATIENTS WITH SPINAL CORD INJURY. PRELIMINARY REPORT.

#583 A pilot study on tamsulosine in the treatment of dry overactive bladder symptoms

#584 The Effects of Hepatic Disease on the Pharmacokinetics of Trospium Chloride

#585 Safety, tolerability and pharmacokinetics of fesoterodine in patients with hepatic impairment

#586 Safety, tolerability and pharmacokinetics of fesoterodine after co-treatment with the potent cytochrome P450 3A4 inhibitor ketoconazole

#587 Predictive factors for the long-term risk of re-treatment and prostatectomy in patients using tamsulosin for lower urinary tract symptoms

#589 What is the effect of LUTS on the quality of life during pregnancy and after childbirth?

#590 OBSTETRICAL RISK FACTORS CONTRIBUTING TO URINE RETENTION > 500 ML 2 HOURS AFTER VAGINAL DELIVERY – A STUDY OF 239 PATIENTS

#591 Peri-partum Stress Incontinence in a Racially Diverse Obstetric Population.

#593 Evaluation of post-voiding residual bladder volume in primaparas day 3 postpartum

#594 Risk factors for anal sphincter injury in Trent – prevention is better than cure?

#595 DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE ICIQ NOCTURIA MODULE: THE ICIQ-N

#596 Validation of an electronic pelvic floor symptoms assessment questionnaire: e-PAQ

#597 Evaluation of treatment of female urinary incontinence with the ICIQ_SF questionnaire

#598 ICIQ PROTOCOL FOR THE DEVELOPMENT OF ALTERNATIVE LANGUAGE VERSIONS OF THE ICIQ-UI SF: THE ARABIC ICIQ-UI SF

#601 Impact of fecal incontinence severity on health domains

#602 IMPACT OF URINARY INCONTINENCE IN FEMALE SEXUALITY

#603 Development of a questionnaire to evaluate the Overactive Bladder Syndrome and its impact on the Quality of Life

#604 A LARGE SCALE INVESTIGATION OF URINARY INCONTINENCE AND GENERIC QUALITY OF LIFE IN HEALTHY FEMALE WORKERS

#607 Involving older users of Continence services in developing standards of care: Differences and similarities between professional and user’s views

#608 Quality of Life following a TVT Revision

#609 Which is the best method to be acceptable enlightenment activities for incontinence patients?

#610 Feasability,complications and short term results of vaginal apex or vault suspension with posterior IVS:preliminary results of 113 cases.

#611 CASE-CONTROL STUDY TO EVALUATE RISK FACTORS FOR PROLAPSE RELAPSE

#612 Posterior Repair with Perforated Porcine Dermal Graft

#613 A prospective randomised trial comparing Pelvicol® and Vicryl® for cystocoele repair in the Raz-colposuspension.

#614 Randomized comparison between infracoccygeal sacropexy (posterior IVS) and sacrospinous fixation in the management of vault prolapse

#616 Does vaginal prolapse surgery improve sexual well being?

#617 PROLAPSE REPAIR BY VAGINAL ROUTE USING A NEW PROTECTED LOW-WEIGHT POLYPROPYLENE MESH: PRELIMINARY RESULTS OF A PROSPECTIVE MULTICENTRE STUDY

#618 A THREE-YEAR FOLLOW-UP OF TENSION-FREE POLYPROPYLENE MESH FOR VAGINAL REPAIR OF ANTERIOR VAGINAL WALL PROLAPSE

#619 Do Alterations in Vaginal Dimensions Following Pelvic Reconstructive Surgeries Affect the Risk for Dyspareunia?

#620 Pelvic organ prolapse treatment by the vaginal route using a Vypro® composite mesh: preliminary results about 106 cases.

#621 Posterior Colporrhaphy with AlloDerm Graft Augmentation: Anatomical and Functional Outcomes

#622 Laparoscopic Sacrocolpopexy and Abdominal Sacrocolpopexy: A Retrospective Comparison

#623 Feasability of a mechanical computed model of the vaginal cavity

#625 A randomized controlled trial comparing povidone-iodine and chlorhexidine to prepare the operative field for vaginal hysterectomy

#627 POSTERIOR IVS ( INFRACOCCYGEAL SACROPEXY) FOR THE TREATMENT OF THE PROLAPSE OF VAGINAL APEX

#628 The use of mesh (Pelvicol)for recurrent or severe anterior defetcs

#629 Supratrigonal vesico vaginal fistula

#630 Preferred Practice in the Management of Vault Prolapse: Results of a Questionnaire Based Survey

#631 Experimental study on the inflammatory cell responses of xenogeneic porcine dermal collagen implantation in mice

#632 Ambulatory prolapse repair: the patients’ perspective.

#634 A double-blind, randomized controlled trial comparing solvent-dehydrated cadaveric fascia lata and polypropylene mesh for sacral colpopexy

#635 Abdominal Sacral Colpopexy: An Independent Prospective Long-term Follow-up Study

#636 Mid vaginal sling for cystocele repair using prolene mesh. A new minimally invasive ambulatory procedure.

#637 Posterior Repair with Dermal Graft:Comparison of Porcine and Human Grafts

#640 The feasibility of vaginal prolapse surgery in daycare

#642 Bovine Pericardium Augmentation Graft for Vaginal Paravaginal Repair of the Anterior Segment

#643 SYMPTOMS AND URODYNAMIC FEATURES AFTER SURGERY FOR PELVIC ORGAN PROLAPSE ASSOCIATED WITH URINARY INCONTINENCE: PRELIMINARY DATA ON AN INTEGRATED APPROACH

#644 Infracoccigeal sacropexy in the treatment of vaginal vault prolapse

#645 VAGINAL VAULT SUSPENSION USING THE POSTERIOR IVS TECHNIQUE

#646 Comparison of pelvic floor tissue-based repair products

#647 Laparoscopic sacral promontory uterine suspension for uterine prolapse

#648 Weight lifting and physical activity limits in patients after anti-incontinence and anti-prolapse surgery

#649 Disposition of Pelvicol 12 Months After Implantation for Pelvic Reconstruction

#650 Heterotopic Transverse Colonic Reservoir: Experimental Sudy in Dogs

#651 A 10 years review of Mitrofanoff continent urinary diversion in adults

#652 TRANS-OBTURATOR TAPE PROCEDURE FOR FEMALE WITH STRESS URINARY INCONTINENCE AND CONCOMITANT PELVIC RECONSTRUCTION SURGERY FOR GENITAL PROLAPSE: ONE YEAR FOLLOW-UP

#653 How to measure the severity of female incontinence. A simple pad test grading system which predicts likely outcome of conservative treatments.

#654 Modified Thiele massage as a therapeutic intervention for female interstitial cystitis patients with high-tone pelvic floor dysfunction

#655 EXTRACORPOREAL MAGNETIC STIMULATION FOR THE TREATMENT OF OVERACTIVE BLADDER SYMPTOMS

#656 Conservative therapy of stress urinary incontinence: 7 years of pelvic-floor-reeducation-program at an university hospital. A retrospective study with follow-up of 434 patients

#657 MULTICENTER RANDOMIZED CONTROLLED TRIAL TO EVALUATE URYX URETHRAL BULKING AGENT IN TREATING FEMALE STRESS URINARY INCONTINENCE: COMPARISON OF INITIAL AND EXPANSION PHASES OF TRIAL

#658 15 YEAR FOLLOW-UP OF A RANDOMIZED CONTROLLED TRIAL OF PELVIC FLOOR MUSCLE TRAINING TO TREAT FEMALE URODYNAMIC STRESS INCONTINENCE

#659 POSTERIOR TIBIAL NERVE STIMULATION (PTNS): IS THE ONCE-A-WEEK PROTOCOL THE BEST OPTION?

#660 Sexual functioning and abuse in patients with lower urinary tract dysfunction treated with posterior tibial nerve stimulation

#663 Failure to Complete Physiotherapy for Stress Incontinence and Prolapse - Predictors and Consequences

#664 comparison between monofilament and multifilament polypropylene tapes in urinary incontinence

#665 Is Ultrasound the Next Dimension in Predicting the Outcome of Continence Surgery?

#667 The Zuidex system for the treatment of stress urinary incontinence: 24-month follow-up

#668 Long term (3 1/2 years) voiding phase changes after TVT. Pressure-flow studies before, one year and 3 1/2 years after TVT.

#669 10 cases of infections with sub-urethral multifilament polypropylene mesh sling requiring removal of the sling

#671 Cadaveric Fascial Transvaginal Sling (CaTS): Five-Year Prospective Follow-Up

#672 Direct cystoscopy assisted tension-free vaginal tape procedure

#673 The effect of body mass index on the result of the Tension-free Vaginal Tape procedure in patients with stress urinary incontinence

#675 DOES THE MONARC® TRANSOBTURATOR SUB-URETHRAL SLING CAUSE POST-OPERATIVE VOIDING DYSFUNCTION? A PROSPECTIVE STUDY.

#676 TRANS-OBTURATOR TAPE T.O.T.:RESULT ON CONTINENCE WITH A ONE YEAR MINIMUM FOLLOW-UP

#679 An Open Clinical Evaluation of Permacol™ Injection as New Urethral Bulking Agent: An Updated 12 Month Follow-Up

#680 Surgical Treatment of Stress Urinary Incontinence: Transvaginal Tape-Obturator Approach Ongoing Data Collection, Outcomes, and Efficacy

#682 Suburethral slings – Are all mesh types the same?

#683 Changes in Tension Properties of Tension-free Vaginal Tape with Soaking Fluids

#686 TRANSOBTURATOR SUB-URETHRAL SUSPENSION: EXPERIENCE OF THE FIRST 62 PATIENTS

#689 Mechanical resistance of synthetics meshes for incontinence or prolapse surgery.

#690 ROLE OF SLING INTEGRITY ON ANTI-INCONTINENCE EFFECTS OF AN ANIMAL MODEL OF SLING PROCEDURE

#691 READJUSTABLE SLING: TRANSOBTURATOR VERSUS TRANSVAGINAL OUTCOME

#692 OUTCOME OF OBESE FEMALE PATIENTS TREATED BY TRANS-OBTURATOR-TAPE FOR STRESS URINARY INCONTINENCE

#693 Comparison of two transobturator suburethral sling techniques

#694 SPARC POLYPROPYLENE MID-URETHRAL SLING IN THE TREATMENT OF STRESS URINARY INCONTINENCE: EARLY RESULTS

#695 Outcome of Suburethral Slings: Early Failure of Porcine Dermal Slings

#697 Are There Predicting Factors For Efficacy And Safety With Combined Pelvic Organ Prolapse Repair And Tension Free Vaginal Tape?

#698 Predisposing Factors of Postoperative Urinary tract infection after tension-free vaginal tape (TVT) procedure for female urinary incontinence

#699 Trans obturator vaginal tape (TOT) for the treatment of female stress incontinence : one year follow-up in 100 patients.

#700 SHORT TERM FOLLOW-UP AFTER TVT AND IVS OPERATIONS: DO WE NEED 3 AND 12 MONTHS EVALUATION?

#701 TENSION FREE VAGINAL TAPE PROCEURE IN THE TREATMENT OF MIXED URINARY INCONTINENCE: SIGNIFICNACE OF MAXIMAL URETHRAL CLOSURE PRESSURE

#702 Persistent Overactive Bladder Symptoms after Anterior Vaginal Wall Sling and Tension-free Vaginal Tape

#703 Cure outcomes and follow-up in the Bologna procedure: a retrospective study

#704 A CLINICAL ASSESSMENT OF GYNCARE TVT with abdominal guides

#705 T.O.T.® : CLINICAL OUTCOME IN ELDERLY FEMALE PATIENTS WITH STRESS URINARY INCONTINENCE.

#706 EFFICACY OF T.O.T.® FOR PATIENTS SUFFERING FROM SUI WITH MAXIMAL URETHRAL CLOSURE PRESSURE LESS THAN 30 CMH2O.

#707 The long-term outcome of fascial sling operation in female stress urinary incontinence : multicenter study in Korea

#708 Six Month Data from the Transobturator Hammock Procedure for Female Stress Urinary Incontinence: A Prospective Study in 8 Countries.

#709 READJUSTABLE SLING: REMEEX LONG TERM RESULTS

#710 Durability of Therapeutic Effects of a Radio Frequency Energy Procedure for Mild-to-Moderate Genuine Stress Incontinence at Three-Year Follow-up

#712 EARLY US EXPERIENCE WITH A TRANSOBTURATOR SLING TO TREAT STRESS INCONTINENCE

#713 Long-Term Followup of Autologous Fascial Pubovaginal Sling for Sphincteric Incontinence in Women

#715 CLINICAL AND URODYNAMICS VARIABLES TO PREDICT THE LATER SPONTANEOUS VOIDING AFTER PUBOVAGINAL SLING SURGERY.

#716 Minimally Invasive Transobturator Technique for the Female Urinary Stress Incontinence(SUI): 103 Cases of Uratape

#718 Subjective und Objective Results After the Tension-free Vaginal Tape (TVT) Operation

#719 Tension-Free Vaginal Tape In The Elderly: Is It a Safe Procedure?

#721 The Effect of Urgency on the Quality of Life After TVT (Tension Free Vaginal Tape) Procedure in Stress Urinary Incontinence Patients

#722 Standardization of TVT Tension Via a Disposable Pressure Sensor

#723 Stress urinary incontinence treatment using a specially design sub uretral support URETEX - Results at 1 year from a multicenter prospective study.

#724 Urinary morbidity from TVT: A conservative approach often works

#726 Veritas Collagen Matrix for use as a urological sling: Results from a prospective study at three U.S. sites.

#728 Tension free procedure for treatment stress incontinent women use IVS anterior (Intravaginal Slingplasty)

#729 IS HYDRODISSECTION NECESSARY AT THE TIME OF TVT?

#730 URODYNAMIC FINDINGS BEFORE AND AFTER PUBOVAGINAL FASCIAL SLING FOR FEMALE STRESS URINARY INCONTINENCE: PREDICTION OF POSTOPERATIVE VOIDING DYSFUNCTION

#731 efficacy of jaluronic acid in the urethral bulking one year follow up

#733 TENSION FREE VAGINAL TAPE PROCEURE IN URINARY INCONTINENCE WITH LOW VALSALVA LEAK POINT PRESSURE

#734 DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE ICIQ URODYNAMICS SATISFACTION MODULE: THE ICIQ-UDS-S

#735 A prospective comparison of data quality from a 3-day urinary diary compared to a 7-day diary

#736 Urodynamic evaluation of changes in urinary control after radical retropubic prostatectomy

#737 CONCENTRIC NEEDLE ELECTRODES ARE SUPERIOR TO PERINEAL SURFACE PATCH ELECTRODES FOR EMG DOCUMENTATION OF URETHRAL SPHINCTER RELAXATION DURING VOIDING

#739 A double-blind, randomised controlled trial of cystometry using Normal saline versus 3M potassium chloride infusion

#740 The Diagnostic Value of Portable Bladder Volume Measurement System (BVMS) with Real Bladder Image in the Measurement of Bladder Volume According to the Different Angling of Transducer

#741 Bladder Dysfunction after Simultaneous Pancreas-Kidney Transplantation

#742 The clinical utility of a two fill and void urodynamic study in women with bladder outlet obstruction (BOO)

#743 Proof of Concept Studies of the Urethral Retro-resistance Pressure: Results of Preliminary Bench, Animate, and Early Human Studies using a MoniTorr™ Prototype

#744 Ambulatory urodynamics; a sensitive method of assessing drug therapy efficacy

#745 EFFECT OF ANESTHETICS ON URODYNAMIC STUDY IN NORMAL RATS

#746 Videourodynamics – Do we really need simultaneously X-ray-imaging?

#747 Development of a biophysical model of the urethra: comparison of viscoelastic properties between PVA models and pig urethrae.

#748 Significance of pad test loss for the evaluation of women with urinary incontinence

#749 The TRS Classification Scheme to Categorize and Quantify Bladder Dysfunction on Urodynamic Findings

#751 Compliance with pad tests: 24 hour pad test compared to the 1 hour pad test

#753 USEFULNESS OF ANTIBIOTIC PROPHYLAXIS IN INVASIVE URODYNAMICS IN FERTILE AND IN POST MENOPAUSAL FEMALE SUBJECTS

#754 THE TRS CLASSIFICATION SYSTEM OF LOWER URINARY TRACT DYSFUNCTION, PART A.

#755 How painful are urodynamic investigations ? Can we change this ?

#756 The Relationship of Maximal Urethral Closure Pressure to Outcome Following Incontinence Surgery.

#757 Classification of detursor acontractility by S3 transrectal electrostimulation

#758 URETHRAL CLOSURE PRESSURE AT REST AND DURING VALSALVA MANEUVRE IN PATIENTS WITH GENUINE STRESS INCONTINENCE

#759 Development of a Flexible Measurement-System for Combined Urodynamic and Neurophysiologic Investigations

#760 Monitoring of uroflowmetry in patients with BPH using Doxazosin

#761 DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE ICIQ VAGINAL SYMPTOMS QUESTIONNAIRE: THE ICIQ-VS

#762 A matched pair cohort analysis of transanal and transvaginal repair of rectocoele

#763 Sexual dysfunction in women with urinary incontinence and/or Pelvic Organ Prolapse as compared with the general population

#765 CLINICAL AND URODYNAMICS RESULTS IN COLPOSACROPEXY AND HYSTEROCOLPOSACROPEXY

#767 Prolene Soft (Gynecare) mesh for pelvic organ prolapse surgical treatment: a prospective study of 264 patients.

#768 DETRUSOR OVERACTIVITY AND UROGENITAL PROLAPSE

#769 MEDIUM TERM REVIEW ON THE OUTCOME OF POSTERIOR COLPORRHAPHY WITH COMPOSITE VICRYL-PROLENE(VYPRO II) MESH

#770 High grade pelvic organ prolapse and clinical and urodynamic findings

#771 Association Between Valsalva and Cough Leak Point Pressure With Pelvic Organ Prolapse in Female Stress Incontinence

#774 The Continued Use of Vaginal Pessaries in the Treatment of Urogenital Prolapse.

#777 Translevator posterior intravaginal slingplasty: short term data on 85 patients.

#778 A simplified approach to pessary management

#779 ANATOMICAL AND FUNCTIONAL OUTCOME IN SURGICAL TREATMENT OF PROLAPSE

#780 Middle Compartment Genital Prolapse. Cervix Elongation Assessment.

#781 THE RELATIONSHIP OF THE CONTENTS OF TOTAL UTERINE PROLAPSE TO THE VOLUME OF ITS HERNIA SAC USING MAGNETIC RESONANCE IMAGING.

#782 The validity of the registration of vaginal prolapse surgery and how to improve the quality

#783 Effect of prior pelvic surgery on clinical and urodynamic parameters in women with high grade pelvic organ prolapse

Comments

Chat

Content Visitors (staff only)